{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:39:21Z","timestamp":1780421961284,"version":"3.54.1"},"reference-count":58,"publisher":"FapUNIFESP (SciELO)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:p>Human growth hormone (hGH) replacement therapy has been widely available for clinical purposes for more than fifty years. Starting in 1958, hGH was obtained from cadaveric pituitaries, but in 1985 the association between hGH therapy and Creutzfeldt-Jakob disease was reported. In the same year, the use of recombinant hGH (rhGH) was approved. Side effects of rhGH replacement therapy in children and adolescents include rash and pain at injection site, transient fever, prepubertal gynecomastia, arthralgia, edema, benign intracranial hypertension, insulin resistance, progression of scoliosis, and slipped capital femoral epiphysis. Since GH stimulates cell multiplication, development of neoplasms is a concern. We will review the side effects reported in all rhGH indications.<\/jats:p>","DOI":"10.1590\/s0004-27302011000800009","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T07:55:24Z","timestamp":1325663724000},"page":"559-565","source":"Crossref","is-referenced-by-count":55,"title":["Adverse effects of growth hormone replacement therapy in children"],"prefix":"10.1590","volume":"55","author":[{"given":"Flavio Moutinho","family":"Souza","sequence":"first","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Ferrez","family":"Collett-Solberg","sequence":"additional","affiliation":[{"name":"UERJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00019616-199303000-00006","article-title":"Creutzfeldt-Jakob disease in pituitary growth hormone recipients","volume":"3","author":"Fradkin JE","year":"1993","journal-title":"Endocrinologist","ISSN":"https:\/\/id.crossref.org\/issn\/1051-2144","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000316130","article-title":"Current indications for growth hormone therapy in children and adolescents","volume":"18","author":"Richmond E","year":"2010","journal-title":"Endocr Dev"},{"key":"ref3","first-page":"2","article-title":"Growth hormone deficiency (GHD) from birth to 2 years of age: diagnostic specifics of GHD during the early phase of life","volume":"60","author":"Ogilvy-Stuart AL","year":"2003","journal-title":"Horm Res","ISSN":"https:\/\/id.crossref.org\/issn\/0301-0163","issn-type":"print"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11102-007-0060-8","article-title":"Management of type 2 diabetes mellitus associated with pituitary gigantism","volume":"10","author":"Ali O","year":"2007","journal-title":"Pituitary","ISSN":"https:\/\/id.crossref.org\/issn\/1386-341X","issn-type":"print"},{"issue":"16","key":"ref5","first-page":"601","article-title":"Efectividad de la hormona de crecimiento recombinante en el d\u00e9ficit de talla debido a retraso de crecimiento intrauterino","volume":"112","author":"Vicens-Calvet E","year":"1999","journal-title":"Med Clin (Barc)."},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1468-1293.2009.00775.x","article-title":"Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism","volume":"11","author":"Hansen BR","year":"2010","journal-title":"HIV Med"},{"issue":"9204","key":"ref7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment","volume":"355","author":"Cutfield WS","year":"2000","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12098-010-0012-6","article-title":"Prepubertal gynecomastia a rare complication of growth hormone therapy","volume":"77","author":"Acharya SV","year":"2010","journal-title":"Indian J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5456","issn-type":"print"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3476(95)70372-1","article-title":"Prepubertal gynecomastia during growth hormone therapy","volume":"126","author":"Malozowski S","year":"1995","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"issue":"9","key":"ref10","first-page":"2135","article-title":"Slipped capital femoral epiphysis","volume":"57","author":"Loder RT","year":"1998","journal-title":"Am Fam Physician","ISSN":"https:\/\/id.crossref.org\/issn\/0002-838X","issn-type":"print"},{"key":"ref11","first-page":"41","article-title":"Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database","volume":"68","author":"Darendeliler F","year":"2007","journal-title":"Horm Res","ISSN":"https:\/\/id.crossref.org\/issn\/0301-0163","issn-type":"print"},{"issue":"3","key":"ref12","first-page":"258","article-title":"Slipped capital femoral epiphysis: diagnosis and management","volume":"82","author":"Peck D","year":"2010","journal-title":"Am Fam Physician","ISSN":"https:\/\/id.crossref.org\/issn\/0002-838X","issn-type":"print"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/BPB.0b013e328318c6f3","article-title":"Southwick's angle determination during growth hormone treatment and its usefulness to evaluate risk of epiphysiolysis","volume":"18","author":"de Andrade AC","year":"2009","journal-title":"J Pediatr Orthop B","ISSN":"https:\/\/id.crossref.org\/issn\/1060-152X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/JPEM.1998.11.2.261","article-title":"Pseudopapilledema and congenital disc anomalies in growth hormone deficiency","volume":"11","author":"Collett-Solberg PF","year":"1998","journal-title":"J Ped Endocrinol Metabol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/JPEM.1993.6.1.99","article-title":"Leukemia and other malignancies among GH users","volume":"6","author":"Watanabe S","year":"1993","journal-title":"J Pediatr Endocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0334-018X","issn-type":"print"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cancergen.2011.04.005","article-title":"Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis","volume":"204","author":"Seif AE","year":"2011","journal-title":"Cancer Genet"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0022-3476(96)70003-3","article-title":"Safety of human growth hormone therapy: Current topics","volume":"128","author":"Allen DB","year":"1996","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar CA","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor study","volume":"91","author":"Ergun-Longmire B","year":"2006","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s007010050177","article-title":"Radiation-induced brain tumours: potential late complications of radiation therapy for brain tumours","volume":"140","author":"Nishio S","year":"1998","journal-title":"Acta Neurochir (Wien)","ISSN":"https:\/\/id.crossref.org\/issn\/0001-6268","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie S","year":"2011","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1210\/jc.2011-1377","article-title":"Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality","volume":"96","author":"Burgers AM","year":"2011","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref23","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated childhood short stature: report of the French SAGhE study","volume":"32","author":"Carel J-C","year":"2011","journal-title":"Endocr Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0163-769X","issn-type":"print"},{"key":"ref24","series-title":"Hormone de Croissance synth\u00e9tique (somatropine recombinante): Premiers r\u00e9sultats de l'\u00e9tude \u00e9pid\u00e9miologique sur la tol\u00e9rance \u00e0 long terme","year":"2010"},{"key":"ref25","series-title":"Information concerning the communication of preliminary results of the French SAGhE study","author":"Carel J-C","year":"2010"},{"key":"ref26","series-title":"FDA drug safety communication: ongoing safety review of recombinant human growth hormone (somatropin) and possible increased risk of death","year":"2011"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1590\/S0004-27302008000500010","article-title":"Baixa estatura na doen\u00e7a renal cr\u00f4nica: fisiopatologia e tratamento com horm\u00f4nio de crescimento","volume":"52","author":"Oliveira JO","year":"2008","journal-title":"Arq Bras Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00467-006-0020-y","article-title":"Consensus committee: Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement","volume":"21","author":"Mahan JD","year":"2006","journal-title":"Pediatr Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0097-5257","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004670050429","article-title":"Growth hormone and renal osteodystrophy: a case report","volume":"12","author":"Kaufman DB","year":"2008","journal-title":"Pediatr Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/0097-5257","issn-type":"print"},{"issue":"5","key":"ref30","first-page":"1704","article-title":"Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience","volume":"81","author":"Blethen SL","year":"1996","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2003.189","article-title":"Adverse events with rhGH treatment of patients with chronic renal insufficiency and end-stage renal disease","volume":"142","author":"Fine RN","year":"2003","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1203\/00006450-199804000-00008","article-title":"The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis: Treatment with recombinant human growth hormone in short children with nephropatic cystinosis: no evidence for increased deterioration rate of renal function","volume":"43","author":"Wiihl E","year":"1998","journal-title":"Pediatr Res","ISSN":"https:\/\/id.crossref.org\/issn\/0031-3998","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(94)92465-1","article-title":"Growth hormone treatment in growth-retarded adolescents after renal transplant","volume":"343","author":"Hokken-Koelega AC","year":"1994","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1755.2002.00489.x","article-title":"Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS","volume":"62","author":"Fine RN","year":"2002","journal-title":"Kidney Int","ISSN":"https:\/\/id.crossref.org\/issn\/0085-2538","issn-type":"print"},{"issue":"3","key":"ref35","first-page":"447","article-title":"Prevalence and incidence of scoliosis in Turner syndrome: a study in 49 girls followed-up for 4 years","volume":"47","author":"Ricotti S","year":"2011","journal-title":"Eur J Phys Rehabil Med"},{"issue":"8859","key":"ref36","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/0140-6736(93)90636-U","article-title":"Effects of human growth hormone therapy on melanocytic naevi","volume":"341","author":"Bourguignon JP","year":"1993","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1096-9896(199609)180:1<74::AID-PATH595>3.0.CO;2-A","article-title":"Naevocyte triggering by recombinant human growth hormone","volume":"180","author":"Pi\u00e9rard GE","year":"1996","journal-title":"J Pathol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3417","issn-type":"print"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1542\/peds.104.S5.1045","article-title":"Melanocytic nevi in children treated with growth hormone","volume":"104","author":"Wyatt D","year":"1999","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jc.2007-1723","article-title":"Long-term safety of recombinant human growth hormone in turner syndrome","volume":"93","author":"Bolar K","year":"2008","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1651-2227.1997.tb18413.x","article-title":"Postnatal growth of children born small for gestational age","volume":"423","author":"Albertsson-Wikland K","year":"1997","journal-title":"Acta Paediatr Suppl","ISSN":"https:\/\/id.crossref.org\/issn\/0803-5326","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1542\/peds.111.6.1253","article-title":"International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001","volume":"111","author":"Lee PA","year":"2003","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref42","first-page":"64","article-title":"American Association of Clinical Endocrinologists Growth Hormone Task Force 2003. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update","volume":"9","author":"Gharib H","year":"2003","journal-title":"Endocr Pract"},{"key":"ref43","series-title":"Norditropin","year":"2003"},{"issue":"66","key":"ref44","article-title":"Latin American Consensus: Children Born Small for Gestational Age","volume":"11","author":"Boguszewski MCS","year":"2011","journal-title":"BMC Pediatr"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1352\/0895-8017(2006)111[193:MIPS]2.0.CO;2","article-title":"Mortality in Prader-Willi Syndrome","volume":"111","author":"Einfeld SL","year":"2006","journal-title":"Am J Ment Retard","ISSN":"https:\/\/id.crossref.org\/issn\/0895-8017","issn-type":"print"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ajmg.a.32131","article-title":"Review of 64 cases of death in children with Prader-Willi syndrome (PWS)","volume":"146","author":"Tauber M","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"2","key":"ref47","first-page":"17","article-title":"Growth hormone and mortality in Prader Willi syndrome","volume":"22","author":"Lee PDK","year":"2006","journal-title":"GGH Journal"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1210\/jc.2009-0454","article-title":"Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome","volume":"94","author":"van Wijngaarden RFA de L","year":"2009","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.spinee.2009.06.017","article-title":"Epidemiological aspects of scoliosis in a cohort of Japanese patients with Prader-Willi syndrome","volume":"9","author":"Nakamura Y","year":"2009","journal-title":"Spine J"},{"issue":"15","key":"ref50","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/ajmg.a.31295","article-title":"Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome","volume":"140","author":"Nagai T","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01241398-200409000-00018","article-title":"High incidence of hip dysplasia but not slipped capital femoral epiphysis in patients with Prader-Willi syndrome","volume":"24","author":"West LA","year":"2004","journal-title":"J Pediatr Orthop","ISSN":"https:\/\/id.crossref.org\/issn\/0271-6798","issn-type":"print"},{"issue":"12","key":"ref52","first-page":"369","article-title":"Body mass index and slipped capital femoral epiphysis","volume":"6","author":"Poussa M","year":"2003","journal-title":"J Pediatr Orthop B","ISSN":"https:\/\/id.crossref.org\/issn\/1060-152X","issn-type":"print"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1302\/0301-620X.90B1.19502","article-title":"Changing incidence of slipped capital femoral epiphysis: a relationship with obesity?","volume":"90","author":"Murray AW","year":"2008","journal-title":"J Bone Joint Surg Br","ISSN":"https:\/\/id.crossref.org\/issn\/0301-620X","issn-type":"print"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1210\/jc.2008-0509","article-title":"on behalf of the 2007 ISS Consensus Workshop participants: Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop","volume":"93","author":"Cohen P","year":"2008","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1210\/jc.2004-2513","article-title":"Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature","volume":"90","author":"Kemp SF","year":"2005","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","article-title":"The tyrosine phosphatase Shp2 in development and cancer","volume":"106","author":"Grossmann KS","year":"2010","journal-title":"Adv Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0065-230X","issn-type":"print"},{"key":"ref57","first-page":"195239","article-title":"Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis","volume":"2011","author":"Liu X","year":"2011","journal-title":"J Signal Transduct"},{"issue":"72","key":"ref58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000243780","article-title":"Growth hormone and the heart in Noonan syndrome","author":"Noordam C","year":"2009","journal-title":"Horm Res","ISSN":"https:\/\/id.crossref.org\/issn\/0301-0163","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v55n8\/09.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T06:03:53Z","timestamp":1640325833000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302011000800009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0004-27302011000800009"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302011000800009","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}